Merger

With $4M GTD, Americas Cardroom's High Five series is back, now featuring elite 'Highest Five' events to attract pros alongside its inclusive schedule.

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.

The company's dividend remains stable, but a reduced reinvestment discount hints at a new focus on acquisitions and cash preservation for the long term.

A new powerhouse is born. The PDI-Robex merger forges a major West African gold company targeting over 400,000 oz per year from its Guinean assets.

With a massive silica resource and key permits, CPS launches a strategic review to close a huge valuation gap, putting its assets in play for the booming solar sector.

Following its Vacasa acquisition, Casago bets on local franchisees in Boise and McCall to fix industry woes and boost community-focused tourism.

A new survey shows nearly half of employers are considering international drug sourcing, a legally murky strategy, as cost control dethrones talent retention.

As Cimpress preps its Q3 results, investors watch to see if record growth can be sustained amid margin pressures in the booming custom print market.

A new program helps heritage brands discreetly adopt AI, enhancing exclusivity and operations behind the scenes without compromising their coveted identity.

Despite major cost cuts and growth in key divisions, DSS, Inc. struggles to convince Wall Street. Can a biotech spin-off finally unlock its true value?

abrdn's VFL fund has postponed its crucial merger vote for a third time, raising questions about shareholder support for its deal with MFS's MFM.

With 62 profitable quarters and a major new acquisition, BioSyent prepares to pitch its proven growth strategy to top healthcare investors in Toronto.

Philip Morris International's upcoming Q1 2026 earnings will be a crucial test of its pivot from cigarettes, with all eyes on ZYN's growth and regulatory hurdles.

ASIC reports a smaller loss but slumping revenue as it sells key NYC properties. With low cash and NYSE warnings, is this a survival plan or a fire sale?

Forward Solutions merges with lighting specialist Sales Lane, a strategic move to enhance technical services and capitalize on California's green energy boom.

From the nation's capital to pristine wilderness, a new report warns that unchecked development and pollution are pushing America's vital rivers to the brink.

Biotech firm Genvor leverages its AI platform in a new partnership, aiming to fast-track novel peptides for anti-aging and weight loss to a booming market.

Energy veteran Scott McNeill joins Infinity's board, bringing a track record of billion-dollar deals and operational scaling to the Appalachian producer.

Amynta Group is combining Scion Underwriting into its Ambridge unit, creating an integrated specialty casualty practice to enhance services for brokers.

The Dallas-based asset manager taps veteran Rob O’Connor to lead a new platform, capitalizing on surging investor demand for liquidity in private credit.